MedPath

Electrofulguration- A novel technique in recipient site preparation in vitiligo surgery.

Not Applicable
Conditions
Health Condition 1: L80- Vitiligo
Registration Number
CTRI/2020/01/022671
Lead Sponsor
Department of Dermatology Venereology and Leprology PGIMER
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

Clinical diagnosis of segmental or non segmental vitiligo

2 independent patchesbof 3x 3 cm size each present symmetrically or unilaterally over the same part or a single patch ofvsize 6x6 cm

Stable leaions for more than 1 year

Disease is not responding to medical therapy for 12 weeks or residual patches post medical therapy

Exclusion Criteria

Pregnancy and lactation

History of unstable cardiac diseasevor pacemakers

Patients with active disease VIDA more than 1

History of hypertrophic scars or keloid

Skin infection

Patients with unrealistic expectations

History of bleeding disorders

Patients on anticoagulants

Immunosuppressed patients

Patients still in wash off period of therapy that is 4 weeks for topical and 12 weeks for systemic therapy

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
To assess the percentage of patients achieving 75 percent repigmentation with respect to the two different methods at 24 weeks of follow up post treatmentTimepoint: 0 4 8 12 16 24 weeks
Secondary Outcome Measures
NameTimeMethod
To assess whether the extent of repigmentation has any correlation to the expression levels of growth factors which are SCF, bFGF, endothelin 1Timepoint: 0 4 8 12 16 24 weeks;To evaluate the repigmentation patterns of the lesions pre and post post procedure by dermoscopy and to ennumerate the dermatoscopic markers of repigmentation as well markers of success of the procedureTimepoint: 0 4 8 12 16 24 weeks
© Copyright 2025. All Rights Reserved by MedPath